BMC Medicine
http://www.biomedcentral.com/bmcmed/content
(Accessed 10 September 2016)
.
Research article
Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysis
Marco Ajelli, Stefano Merler, Laura Fumanelli, Ana Pastore y Piontti, Natalie E. Dean, Ira M. Longini, M. Elizabeth Halloran and Alessandro Vespignani
Abstract
Background
Among the three countries most affected by the Ebola virus disease outbreak in 2014–2015, Guinea presents an unusual spatiotemporal epidemic pattern, with several waves and a long tail in the decay of the epidemic incidence.
Methods
Here, we develop a stochastic agent-based model at the level of a single household that integrates detailed data on Guinean demography, hospitals, Ebola treatment units, contact tracing, and safe burial interventions. The microsimulation-based model is used to assess the effect of each control strategy and the probability of elimination of the epidemic according to different intervention scenarios, including ring vaccination with the recombinant vesicular stomatitis virus-vectored vaccine.
Results
The numerical results indicate that the dynamics of the Ebola epidemic in Guinea can be quantitatively explained by the timeline of the implemented interventions. In particular, the early availability of Ebola treatment units and the associated isolation of cases and safe burials helped to limit the number of Ebola cases experienced by Guinea. We provide quantitative evidence of a strong negative correlation between the time series of cases and the number of traced contacts. This result is confirmed by the computational model that suggests that contact tracing effort is a key determinant in the control and elimination of the disease. In data-driven microsimulations, we find that tracing at least 5–10 contacts per case is crucial in preventing epidemic resurgence during the epidemic elimination phase. The computational model is used to provide an analysis of the ring vaccination trial highlighting its potential effect on disease elimination.
Conclusions
We identify contact tracing as one of the key determinants of the epidemic’s behavior in Guinea, and we show that the early availability of Ebola treatment unit beds helped to limit the number of Ebola cases in Guinea.

BMC Medicine
http://www.biomedcentral.com/bmcmed/content
(Accessed 10 September 2016)

Commentary
Infectious diseases epidemic threats and mass gatherings: refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV)
Alimuddin Zumla, Abdulaziz N. Alagaili, Matthew Cotten and Esam I. Azhar
BMC Medicine 2016 14:132
Published on: 7 September 2016
Abstract
Media and World Health Organization (WHO) attention on Zika virus transmission at the 2016 Rio Olympic Games and the 2015 Ebola virus outbreak in West Africa diverted the attention of global public health authorities from other lethal infectious diseases with epidemic potential. Mass gatherings such as the annual Hajj pilgrimage hosted by Kingdom of Saudi Arabia attract huge crowds from all continents, creating high-risk conditions for the rapid global spread of infectious diseases. The highly lethal Middle Eastern respiratory syndrome coronavirus (MERS-CoV) remains in the WHO list of top emerging diseases likely to cause major epidemics. The 2015 MERS-CoV outbreak in South Korea, in which 184 MERS cases including 33 deaths occurred in 2 months, that was imported from the Middle East by a South Korean businessman was a wake-up call for the global community to refocus attention on MERS-CoV and other emerging and re-emerging infectious diseases with epidemic potential. The international donor community and Middle Eastern countries should make available resources for, and make a serious commitment to, taking forward a “One Health” global network for proactive surveillance, rapid detection, and prevention of MERS-CoV and other epidemic infectious diseases threats.

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 10 September 2016)

Research article
The social patterning of risk factors for noncommunicable diseases in five countries: evidence from the modeling the epidemiologic transition study (METS)
Associations between socioeconomic status (SES) and risk factors for noncommunicable diseases (NCD-RFs) may differ in populations at different stages of the epidemiological transition. We assessed the social p…
Silvia Stringhini, Terrence E. Forrester, Jacob Plange-Rhule, Estelle V. Lambert, Bharathi Viswanathan, Walter Riesen, Wolfgang Korte, Naomi Levitt, Liping Tong, Lara R. Dugas, David Shoham, Ramon A. Durazo-Arvizu, Amy Luke and Pascal Bovet

Debate
Schools of public health in low and middle-income countries: an imperative investment for improving the health of populations?
Public health has multicultural origins. By the close of the nineteenth century, Schools of Public Health (SPHs) began to emerge in western countries in response to major contemporary public health challenges….
Fauziah Rabbani, Leah Shipton, Franklin White, Iman Nuwayhid, Leslie London, Abdul Ghaffar, Bui Thi Thu Ha, Göran Tomson, Rajiv Rimal, Anwar Islam, Amirhossein Takian, Samuel Wong, Shehla Zaidi, Kausar Khan, Rozina Karmaliani, Imran Naeem Abbasi…

Conflict and Health
http://www.conflictandhealth.com/
[Accessed 10 September 2016]

Research
Mental health and psychosocial support for South Sudanese refugees in northern Uganda: a needs and resource assessment
Alex Adaku, James Okello, Blakeley Lowry, Jeremy C. Kane, Stephen Alderman, Seggane Musisi and Wietse A. Tol
Published on: 7 September 2016
Abstract
Background
Since December 2013, an armed conflict in South Sudan has resulted in the displacement of over 2.2 million people, more than 270,000 of whom are presently in refugee settlements located throughout Uganda. Existing literature suggests that refugees are at increased risk for a range of mental health and psychosocial problems. There is international consensus on the importance of needs and resource assessments to inform potential mental health and psychosocial support (MHPSS) interventions.
Methods
We conducted a MHPSS needs and resource assessment in Rhino Camp refugee settlement in northern Uganda, between June and August 2014. We followed World Health Organization (WHO) and United Nations High Commissioner for Refugees (UNHCR) guidelines for MHPSS needs assessments in humanitarian settings. The assessment used a range of methodologies including: 1) a desk (literature) review to understand the context for mental health service provision; 2) an analysis of data from existing health information systems (HIS); 3) an assessment of the current infrastructure for service provision using a shortened version of a Who does What Where until When (4Ws); and 4) semi-structured individual and group interviews (total n = 86) with key informants (n = 13) and general community members (individual interviews n = 28, four focus groups with n = 45).
Results
Data from the HIS indicated that visits to health centers in refugee settlements attributable to psychotic disorders, severe emotional disorders, and other psychological complaints increased following the refugee influx between 2013 and 2014, but overall help-seeking from health centers was low compared to estimates from epidemiological studies. In semi-structured interviews the three highest ranked mental health and psychosocial problems included “overthinking”, ethnic conflict, and child abuse. Other concerns included family separation, drug abuse, poverty, and unaccompanied minors. The 4Ws assessment revealed that there were very limited MHPSS services available in Rhino Camp.
Conclusions
The types of MHPSS problems among South Sudanese refugees in northern Uganda are diverse and the burden appears to be considerable, yet there are currently few available services. The assessment indicates the need for a range of services addressing social concerns as well as varied types of mental conditions. The idiom of “overthinking” may form a useful starting point for intervention development and mental health communication.

Globalization and Health
http://www.globalizationandhealth.com/
[Accessed 10 September 2016]

Research
Mapping of research on maternal health interventions in low- and middle-income countries: a review of 2292 publications between 2000 and 2012
Matthew Chersich, Duane Blaauw, Mari Dumbaugh, Loveday Penn-Kekana, Siphiwe Thwala, Leon Bijlmakers, Emily Vargas, Elinor Kern, Josephine Kavanagh, Ashar Dhana, Francisco Becerra-Posada, Langelihle Mlotshwa, Victor Becerril-Montekio, Priya Mannava, Stanley Luchters, Minh Duc Pham…
Published on: 6 September 2016
Abstract
Background
Progress in achieving maternal health goals and the rates of reductions in deaths from individual conditions have varied over time and across countries. Assessing whether research priorities in maternal health align with the main causes of mortality, and those factors responsible for inequitable health outcomes, such as health system performance, may help direct future research. The study thus investigated whether the research done in low- and middle-income countries (LMICs) matched the principal causes of maternal deaths in these settings.
Methods
Systematic mapping was done of maternal health interventional research in LMICs from 2000 to 2012. Articles were included on health systems strengthening, health promotion; and on five tracer conditions (haemorrhage, hypertension, malaria, HIV and other sexually transmitted infections (STIs)). Following review of 35,078 titles and abstracts in duplicate, data were extracted from 2292 full-text publications.
Results
Over time, the number of publications rose several-fold, especially in 2004–2007, and the range of methods used broadened considerably. More than half the studies were done in sub-Saharan Africa (55.4 %), mostly addressing HIV and malaria. This region had low numbers of publications per hypertension and haemorrhage deaths, though South Asia had even fewer. The proportion of studies set in East Asia Pacific dropped steadily over the period, and in Latin America from 2008 to 2012. By 2008–2012, 39.1 % of articles included health systems components and 30.2 % health promotion. Only 5.4 % of studies assessed maternal STI interventions, diminishing with time. More than a third of haemorrhage research included health systems or health promotion components, double that of HIV research.
Conclusion
Several mismatches were noted between research publications, and the burden and causes of maternal deaths. This is especially true for South Asia; haemorrhage and hypertension in sub-Saharan Africa; and for STIs worldwide. The large rise in research outputs and range of methods employed indicates a major expansion in the number of researchers and their skills. This bodes well for maternal health if variations in research priorities across settings and topics are corrected.

Health Affairs
September 2016; Volume 35, Issue 9
http://content.healthaffairs.org/content/current
Issue Focus: Payment Reforms, Prescription Drugs & More

Global
Training And Supervision Did Not Meaningfully Improve Quality Of Care For Pregnant Women Or Sick Children In Sub-Saharan Africa
Hannah H. Leslie, Anna Gage, Humphreys Nsona, Lisa R. Hirschhorn, and Margaret E. Kruk
Health Aff September 2016 35:1716-1724; doi:10.1377/hlthaff.2016.0261
Abstract
In-service training courses and supportive supervision of health workers are among the most common interventions to improve the quality of health care in low- and middle-income countries. Despite extensive investment from donors, evaluations of the long-term effect of these two interventions are scarce. We used nationally representative surveys of health systems in seven countries in sub-Saharan Africa to examine the association of in-service training and supervision with provider quality in antenatal and sick child care. The results of our analysis showed that observed quality of care was poor, with fewer than half of evidence-based actions completed by health workers, on average. In-service training and supervision were associated with quality of sick child care; they were associated with quality of antenatal care only when provided jointly. All associations were modest—at most, improvements related to interventions were equivalent to 2 additional provider actions out of the 18–40 actions expected per visit. In-service training and supportive supervision as delivered were not sufficient to meaningfully improve the quality of care in these countries. Greater attention to the quality of health professional education and national health system performance will be required to provide the standard of health care that patients deserve.

Infectious Diseases of Poverty
http://www.idpjournal.com/content
[Accessed 10 September 2016]

Research Article
Bibliometric study of research and development for neglected diseases in the BRICS
Large numbers of people are suffering from a group of diseases that mainly affect developing countries, as there are no available or affordable products for prevention or treatment. Research and development (R…
Jing Bai, Wei Li, Yang-Mu Huang and Yan Guo

JAMA
September 6, 2016, Vol 316, No. 9
http://jama.jamanetwork.com/issue.aspx

Editorial
The Challenge of Latent TB Infection FREE
Henry M. Blumberg, MD; Joel D. Ernst, MD

US Preventive Services Task Force
Recommendation Statement
Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement FREE

Evidence Report
Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force FREE
Leila C. Kahwati, MD, MPH; Cynthia Feltner, MD, MPH; Michael Halpern, MD, PhD, MPH; Carol L. Woodell, BSPH; Erin Boland, BA; Halle R. Amick, MSPH; Rachel Palmieri Weber, PhD; Daniel E. Jonas, MD, MPH

JAMA Pediatrics
September 2016, Vol 170, No. 9
http://archpedi.jamanetwork.com/issue.aspx

Editorial
Infant Protection Against Influenza Through Maternal Immunization: A Call for More Immunogenic Vaccines
Flor M. Munoz, MD

Original Investigation
Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical Trial
Marta C. Nunes, PhD; Clare L. Cutland, MD; Stephanie Jones, MD; Andrea Hugo, MD; Richard Madimabe, BTech; Eric A. F. Simões, MD; Adriana Weinberg, MD; Shabir A. Madhi, MD, PhD; for the Maternal Flu Trial Team
Abstract
Importance
Influenza immunization of women during pregnancy protects the young infants against influenza illness. The duration of this protection remains unclear.
Objective
To evaluate the duration of infant protection conferred by maternal immunization and its association with transplacental antibody transfer.
Design, Setting, and Participants
Infants born to women who participated in a randomized, double-blind, placebo-controlled clinical trial in 2011 and 2012 on the safety, immunogenicity, and efficacy of trivalent inactivated influenza vaccine (IIV3) during pregnancy were followed up during the first 6 months of life for polymerase chain reaction (PCR)–confirmed influenza illness. In a secondary analysis of a subset of infants, hemagglutination inhibition (HAI) antibodies were measured. The study was performed at a single center in South Africa. The secondary analysis was performed in October 2014.
Exposure
Maternal immunization for influenza.
Main Outcomes and Measures
The vaccine’s efficacy against PCR-confirmed influenza illness and the percentage of infants with HAI titers of 1:40 or more by age group.
Results
There were 1026 infants (47.2% female) born to IIV3 recipients and 1023 infants (47.3% female) born to placebo recipients who were included in the analysis of the vaccine’s efficacy. The vaccine’s efficacy against PCR-confirmed influenza illness was highest among infants 8 weeks of age or younger at 85.6% (95% CI, 38.3%-98.4%) and decreased with increasing age to 25.5% (95% CI, −67.9% to 67.8%) among infants 8 to 16 weeks of age and to 30.3% (95% CI, −154.9% to 82.6%) among infants 16 to 24 weeks of age. Similarly, in the IIV3 group, the percentage of infants with HAI titers of 1:40 or more to the influenza vaccine strains decreased from more than 56% in the first week of life to less than 40% at 16 weeks of age and less than 10.0% at 24 weeks of age.
Conclusions and Relevance
Maternal immunization conferred protection against infection in the infants for a limited period during early life. The lack of protection beyond 8 weeks of age correlated with a decrease in maternally derived antibodies.
Trial Registration
clinicaltrials.gov Identifier: NCT01306669

Journal of Human Trafficking
Volume 2, Issue 3, 2016
http://www.tandfonline.com/toc/uhmt20/current

research article
Child Sex-Trafficking Recognition, Intervention, and Referral: An Educational Framework for the Development of Health-Care-Provider Education Programs
23 Aug 2016
Cathy L. Miller, Gloria Duke & Sally Northam

research article
International Sporting Events and Human Trafficking: Effects of Mega-Events on a State’s Capacity to Address Human Trafficking
23 Aug 2016
Zack Bowersox

book review
Review of International Sex Trafficking of Women & Children – Understanding the Global Epidemic
02 Aug 2016
Yvon Dandurand

book review
Review of Global Human Trafficking: Critical Issues and Contexts
02 Aug 2016
Benjamin Thomas Greer

Journal of Immigrant and Minority Health
Volume 18, Issue 5, October 2016
http://link.springer.com/journal/10903/18/5/page/1

Original Paper
Latent Tuberculosis Infection Among Immigrant and Refugee Children Arriving in the United States: 2010
Eboni M. Taylor, John Painter, Drew L. Posey…

Original Paper
Behavioral and Environmental Explanations of Elevated Blood Lead Levels in Immigrant Children and Children of Immigrants
Stan A. Kaplowitz, Harry Perlstadt…

Original Paper
Immunization Coverage in Migrant School Children Along the Thailand-Myanmar Border
Aiko Kaji, Daniel M. Parker, Cindy S. Chu…

Original Paper
HPV Vaccine and Latino Immigrant Parents: If They Offer It, We Will Get It
Abraham Aragones, Margaux Genoff…

Journal of Infectious Diseases
Volume 214 Issue 6 September 15, 2016
http://jid.oxfordjournals.org/content/current

EDITORIAL COMMENTARIES
Editor’s choice: Dengue Vaccine: The Need, the Challenges, and Progress
Alan L. Rothman and Francis A. Ennis
J Infect Dis. (2016) 214 (6): 825-827 doi:10.1093/infdis/jiw068

Public Health Benefits of Routine Human Papillomavirus Vaccination for Adults in the Netherlands: A Mathematical Modeling Study
Suzette M. Matthijsse, Jan A. C. Hontelez, Steffie K. Naber, Kirsten Rozemeijer, Inge M. C. M. de Kok, Roel Bakker, Marjolein van Ballegooijen, Joost van Rosmalen, and Sake J. de Vlas
J Infect Dis. (2016) 214 (6): 854-861 doi:10.1093/infdis/jiw256

Journal of International Development
August 2016 Volume 28, Issue 6 Pages 825–1010
http://onlinelibrary.wiley.com/doi/10.1002/jid.v28.6/issuetoc

.
Research Articles
Training Professionals and Eroding Relationships: Donors, Aids Care and Development in Urban Zambia (pages 827–844)
Amy S. Patterson
Version of Record online: 26 APR 2016 | DOI: 10.1002/jid.3222

Research Articles
Determinants and Trends of Socioeconomic Inequality in Child Malnutrition: The Case of Mozambique, 1996–2011 (pages 857–875)
Vincenzo Salvucci
Version of Record online: 6 AUG 2015 | DOI: 10.1002/jid.3135

Field Report
Deregulation and Access to Medicines: the Peruvian Experience (pages 997–1005)
Joan Costa Font
Version of Record online: 10 APR 2015 | DOI: 10.1002/jid.3096
Abstract
How does the deregulation of medicine influence access to drugs? This paper provides an economic policy assessment of the effects of medicine deregulation drawing on the Peruvian experience between 1991 and 2006. As in other low-income countries, health insurance development is inadequate, drug expenditure is mostly paid out-of-pocket and approximately one third of the Peruvian population has limited access to ‘essential medicines’. Market deregulation in this context could have exerted an impact on prices and hence reduce access to medicines. Based on this evidence, we find that product and price deregulation of the medicines market appears to have reduced consumer trust of locally produced medicines and incentivised a switch to branded and more expensive drugs. The latter resulted in a drug price spike, which in turn further decreased access to medicines.

The Lancet
Sep 10, 2016 Volume 388 Number 10049 p1025-1128 e2-e3
http://www.thelancet.com/journals/lancet/issue/current

.
Series
HIV and related infections in prisoners
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
Kate Dolan, Andrea L Wirtz, Babak Moazen, Martial Ndeffo-mbah, Alison Galvani, Stuart A Kinner, Ryan Courtney, Martin McKee, Joseph J Amon, Lisa Maher, Margaret Hellard, Chris Beyrer, Fredrick L Altice

HIV and related infections in prisoners
Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis
Josiah D Rich, Curt G Beckwith, Alexandria Macmadu, Brandon D L Marshall, Lauren Brinkley-Rubinstein, Joseph J Amon, M-J Milloy, Maximilian R F King, Jorge Sanchez, Lukoye Atwoli, Frederick L Altice

HIV and related infections in prisoners
Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners
Adeeba Kamarulzaman, Stewart E Reid, Amee Schwitters, Lucas Wiessing, Nabila El-Bassel, Kate Dolan, Babak Moazen, Andrea L Wirtz, Annette Verster, Frederick L Altice
1115

New England Journal of Medicine
September 8, 2016 Vol. 375 No. 10
http://www.nejm.org/toc/nejm/medical-journal

.
Perspective
Need for a New Lyme Disease Vaccine
S.A. Plotkin
Despite the development of two vaccines against Borrelia burgdorferi, the bacterium that causes Lyme disease, there is no such vaccine currently on the market. But the problem of Lyme disease is large and growing. Fortunately, the future seems reasonably bright for new vaccines.

.
Review Article
The Changing Face of Clinical Trials: The Primary Outcome Is Positive — Is That Good Enough?
S.J. Pocock and G.W. Stone
There is a natural tendency to simplify the findings of a clinical trial into a binary conclusion: “Was there a positive outcome — or not?” In order to address this question with some objectivity, attention is typically focused on whether the prespecified measure of success for the primary outcome has been met — that is, whether a P value of less than 0.05 has been achieved for the difference in treatments. In reality, a more nuanced interpretation requires a thorough examination of the totality of the evidence, including secondary end points, safety issues, and the size and quality of the trial. In this article, which focuses on the evaluation of “positive” studies — as in our previous article,1 which focused on the appraisal of “negative” studies — our intent is to facilitate a more sophisticated and balanced interpretation of trial evidence. Again, we make our points using examples from trials involving cardiovascular disease (our area of expertise), but the messages can be easily applied to other subject areas.

PLoS Currents: Outbreaks
http://currents.plos.org/outbreaks/
(Accessed 10 September 2016)

.
Isolation of Zika Virus Imported from Tonga into Australia
September 7, 2016 · Research Article
Introduction: The globally emergent Zika virus (ZIKV) is a threat to Australia, given the number of imported cases from epidemic regions and the presence of competent mosquito vectors. We report the isolation of ZIKV from a female traveler who recently returned from Tonga to Brisbane, Queensland, Australia in 2016.
Methods: A specific TaqMan real-time reverse transcriptase polymerase chain reaction assay (RT-PCR) assay was used to detect ZIKV in serum and urine samples. Conventional cell culture techniques and suckling mice were employed in an attempt to isolate ZIKV from serum and urine.
Results: A ZIKV isolate (TS17-2016) was recovered from the serum sample after one passage in suckling mouse brains and harvested 11 days post inoculation. Phylogenetic analysis of complete envelope (E) gene sequences demonstrated TS17-2016 shared 99.9% nucleotide identity with other contemporary sequences from Tonga 2016, Brazil 2015 and French Polynesia 2013 within the Asian lineage.
Discussion: This is the first known report of successful isolation of ZIKV from a human clinical sample in Australia and the first from a traveler from Tonga. This study highlights the potential difficulties in isolating ZIKV from acute clinical samples using conventional cell culture techniques, particularly in non-endemic countries like Australia where access to samples of sufficient viral load is limited. The successful isolation of TS17-2016 will be essential for continued investigations of ZIKV transmission and pathogenicity and will enable the advancement of new preventative control measures extremely relevant to the Australian and Pacific region.

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 10 September 2016)
.
Research Article
Sex Differences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis
Katherine C. Horton, Peter MacPherson, Rein M. G. J. Houben, Richard G. White, Elizabeth L. Corbett
| published 06 Sep 2016 PLOS Medicine
http://dx.doi.org/10.1371/journal.pmed.1002119

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 10 September 2016)
.

A Médecins Sans Frontières Ethics Framework for Humanitarian Innovation
Julian Sheather, Kiran Jobanputra, Doris Schopper, John Pringle, Sarah Venis, Sidney Wong, Robin Vincent-Smith
Health in Action | published 06 Sep 2016 PLOS Medicine
http://dx.doi.org/10.1371/journal.pmed.1002111
Summary Points
:: Humanitarian organisations often have to innovate to deliver health care and aid to populations in complex and volatile contexts.
:: Innovation projects can involve ethical risks and have consequences for populations even if human participants are not directly involved. While high-level principles have been developed for humanitarian innovation, there is a lack of guidance for how these should be applied in practice.
: Médecins sans Frontières (MSF) has well-established research ethics frameworks, but application of such frameworks to innovation projects could stifle innovation by introducing regulation disproportionate to the risks involved. In addition, the dynamic processes of innovation do not fit within conventional ethics frameworks.
:: MSF developed and is piloting an ethics framework for humanitarian innovation that is intended for self-guided use by innovators or project owners to enable them to identify and weigh the harms and benefits of such work and be attentive towards a plurality of ethical considerations.

PLoS Neglected Tropical Diseases
http://www.plosntds.org/
[Accessed 10 September 2016]

.
Research Article
The Global Economic and Health Burden of Human Hookworm Infection
Sarah M. Bartsch, Peter J. Hotez, Lindsey Asti, Kristina M. Zapf, Maria Elena Bottazzi, David J. Diemert, Bruce Y. Lee
published 08 Sep 2016 PLOS Neglected Tropical Diseases
http://dx.doi.org/10.1371/journa

PLoS One
http://www.plosone.org/
[Accessed 10 September 2016]
.
Research Article
Challenges of Estimating the Annual Caseload of Severe Acute Malnutrition: The Case of Niger
Hedwig Deconinck, Anaïs Pesonen, Mahaman Hallarou, Jean-Christophe Gérard, André Briend, Philippe Donnen, Jean Macq
Research Article | published 08 Sep 2016 PLOS ONE
http://dx.doi.org/10.1371/journal.pone.0162534